Revati Shreeniwas

Revati Shreeniwas

Presidente presso
Revati, Inc.
65 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Revati Shreeniwas is President at Revati, Inc. since 2004.
Also a Member at Continuing Medical Education, Inc. Former roles include Principal at Scios, Inc., CV Therapeutics, Inc., and The Trustees of Columbia University in The City of New York.
Served as Vice President-Clinical Research & Development at Alvine Pharmaceuticals, Inc. Vice President-Clinical Development at Soleno Therapeutics, Inc. from 2019 to 2020.
Professor at Stanford University.
Chief Medical Officer at NeurAxon Pharma, Inc. from 2015 to 2017 and at Bright Minds Biosciences, Inc. from 2020 to 2022.

Posizioni attive di Revati Shreeniwas

SocietàPosizioneInizio
Corporate Officer/Principal -
Revati, Inc.
Presidente 01/01/2004

Precedenti posizioni note di Revati Shreeniwas

SocietàPosizioneFine
BRIGHT MINDS BIOSCIENCES INC. Direttore Tecnico/Scientifico/R&S 01/12/2022
SOLENO THERAPEUTICS, INC. Direttore Tecnico/Scientifico/R&S 01/06/2020
Direttore Tecnico/Scientifico/R&S 01/01/2017
Corporate Officer/Principal -
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Revati Shreeniwas

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

15

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private10

Health Technology

Health Technology

Revati, Inc.

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

  1. Mercati
  2. Insiders
  3. Revati Shreeniwas